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The c-Jun NH2-terminal kinase (JNK) group of mitogen-activated protein kinases (MAPKs) is activated in
response to the treatment of cells with inflammatory cytokines and by exposure to environmental stress. JNK
activation is mediated by a protein kinase cascade composed of a MAPK kinase and a MAPK kinase kinase.
Here we describe the molecular cloning of a putative molecular scaffold protein, JIP3, that binds the protein
kinase components of a JNK signaling module and facilitates JNK activation in cultured cells. JIP3 is
expressed in the brain and at lower levels in the heart and other tissues. Immunofluorescence analysis
demonstrated that JIP3 was present in the cytoplasm and accumulated in the growth cones of developing
neurites. JIP3 is a member of a novel class of putative MAPK scaffold proteins that may regulate signal
transduction by the JNK pathway.
Mitogen-activated protein kinase (MAPK) signal transduc-
tion pathways are evolutionarily conserved in eukaryotic cells
and have been identified in plants, yeast, insects, nematodes,
and mammals. Genetic studies have established that MAPK
signaling pathways are critical mediators of the response of
cells to changes in their environment. Thus, MAPK pathways
are essential for complex physiological processes (for example,
embryonic development and the immune response) and regu-
late cell survival, apoptosis, proliferation, and migration (24,
44, 49, 62). MAPKs are activated by conserved signaling mod-
ules that function as a protein kinase cascade. Dual phosphor-
ylation on threonine and tyrosine residues within a Thr-Xaa-
Tyr motif located in protein kinase subdomain VIII causes
MAPK activation. This phosphorylation is mediated by a dual-
specificity protein kinase (MAPK kinase [MAPKK]) which, in
turn, is activated by phosphorylation mediated by a serine/
threonine protein kinase (MAPKK kinase [MAPKKK]).
In the yeast Saccharomyces cerevisiae, five MAPK pathways
that regulate mating, sporulation, filamentation, osmoregula-
tion, and cell wall biosynthesis have been described (2, 32). In
mammals, three major groups of MAPKs have been identified
by molecular cloning (24, 44). These include the extracellular
signal-regulated protein kinases (ERK), the p38 MAPKs, and
the c-Jun NH2-terminal kinases (JNK). The physiological role
of each of these groups of MAPKs has not been fully eluci-
dated. However, each group of mammalian MAPKs is acti-
vated by a distinct signaling module and appears to be coupled
to different biological responses.
The JNK group of MAPKs is activated by treatment of cells
with inflammatory cytokines and by exposure to environmental
stress. Biochemical studies demonstrate that the JNK protein
kinases phosphorylate the NH2-terminal activation domain of
components of the AP-1 transcription factor, including c-Jun
and ATF2 (24). Phosphorylation by JNK increases AP-1 tran-
scription activity. Thus, the JNK signaling pathway contributes
to the regulation of AP-1 activity. This conclusion is supported
by genetic evidence that Jun mediates some effects of the JNK
signaling pathway (21, 41, 52) and by the observation that mice
with targeted disruptions of genes that encode components of
the JNK signaling pathway exhibit defects in stress-induced
AP-1 transcription activity (67–69).
Recent studies of model genetic organisms have established
physiological roles for the JNK signaling pathway. In the insect
Drosophila melanogaster, JNK is required for early embryonic
morphogenesis. JNK-deficient animals fail to initiate dorsal
closure, a morphogenetic process in which the lateral epider-
mal cells spread (elongate and migrate) to cover the dorsal
surface of the embryo (42, 53). JNK is also required for some
forms of developmental apoptosis in Drosophila (1). In the
nematode Caenorhabditis elegans, JNK is required for the nor-
mal function of type D GABAergic (GABA; g-aminobutyric
acid) motor neurons (26). The physiological role of the mam-
malian JNK signaling pathway has also been studied. Three
genes encode the JNK protein kinase in mammals. The Jnk1
and Jnk2 genes are expressed ubiquitously, while the Jnk3 gene
is expressed primarily in the brain (8, 16, 25, 28, 51). The JNK
signaling pathway contributes to neuronal apoptosis in re-
sponse to stress (4, 10, 64, 69) and during development (27).
JNK is also required for apoptosis of CD41 CD81 double-
positive thymocytes caused by anti-CD3 in vivo (43, 45). The
JNK signaling pathway can also contribute to proliferative
responses (24). In addition, the JNK signaling pathway is
critical for immune cell function because Jnk12/2 (11) and
Jnk22/2 (45, 68) mice exhibit defective immune responses.
Further studies are required to fully establish the physiological
role of the JNK signaling pathway. However, the studies out-
lined above demonstrate that the JNK pathway provides a
mechanism that cells employ to mount an appropriate re-
sponse to extracellular stimulation (24).
The JNK protein kinases are activated by evolutionarily con-
served signaling modules that include MKK4 and MKK7 (24).
Molecular cloning studies have identified MKK4 in mammals
(9, 30, 47) and Drosophila (18). Similarly, the MKK7 protein
kinase has been identified in mammals and Drosophila (15, 20,
35, 58, 59). Genetic analysis of Drosophila and gene targeting
studies in mice demonstrate that MKK4 and MKK7 serve
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nonredundant roles during development (14, 15, 36, 37, 56,
67). The MKK4 and MKK7 protein kinases are phosphory-
lated and activated in response to extracellular stimulation by
several MAPKKKs, including ASK1, TAK1, TPL2, and mem-
bers of the MLK and MEKK groups (62).
The JNK signaling cascade can be reconstituted in vitro with
purified JNK, MKK4 or MKK7, and a MAPKKK. However, it
is likely that the JNK signaling cascade may be organized into
defined modules in vivo (61). Thus, the MAPKKK MEKK1
binds to JNK, MKK4, and the Ste20p-related protein kinase
NIK (54, 63, 65). Transmission of signals from MEKK1 to JNK
may be facilitated by the formation of this complex in vivo (61).
Functional signaling modules could also be created by the
interaction of JNK signaling pathway components with other
proteins (61). Recent studies have identified JIP1 (60) and
JIP2 (70) as putative scaffold proteins that interact with mul-
tiple components of a JNK signaling module and facilitate JNK
activation in vivo (61). A second example of a putative mam-
malian scaffold protein, MP1, was found to function within the
ERK MAPK pathway (48). It is likely that such scaffold com-
plexes contribute to the regulation of MAPK activation in vivo
because previous studies of MAPK signaling in yeast have
established that the activation and function of the mating
MAPK pathway requires the scaffold protein Ste5p (6, 34, 39).
A scaffolding function for Pbs2p in the yeast osmoregulatory
MAPK pathway has also been reported (38). Thus, scaffold
proteins are established, at least in some MAPK pathways, to
be critical for physiological control of signal transduction.
However, the number and function of other possible scaffold
proteins that interact with MAPK signaling modules remain to
be elucidated.
The purpose of the study described in this report was to
identify a novel mammalian scaffold protein that interacts with
a MAPK signaling module. We demonstrate that the JIP3
protein interacts with components of a JNK signaling module
and facilitates JNK activation in vivo. JIP3 is structurally dis-
tinct from the previously identified JIP proteins and represents
the founding member of a new class of putative MAPK scaffold
proteins.
MATERIALS AND METHODS
Molecular cloning of JIP3. Partial JIP3 cDNA clones were isolated from a
mouse embryo cDNA library by the two-hybrid method using S. cerevisiae L40 (7,
10). The bait plasmid (pLexA-JNK1) was constructed by the insertion of the
JNK1 cDNA in the polylinker of plasmid pBTM116 (7, 10). A full-length JIP3a
cDNA clone was isolated from a mouse heart Uni-ZAPXR library (Stratagene
Inc.), and a full-length JIP3b cDNA clone was isolated from a mouse brain
lZAPII library (Stratagene) by plaque hybridization using a JIP3 cDNA frag-
ment as a probe. The largest clones obtained (5,442 and 5,562 bp) included the
complete open reading frame of mouse JIP3a and JIP3b. The sequences of these
JIP3 cDNA clones were determined with an Applied Biosystems 373A machine.
Plasmids. Expression vectors for JIP3 were constructed from plasmids
pCDNA3 (Invitrogen Inc.), pEBG (47) and pGEX (Amersham Pharmacia Bio-
tech Inc.) by subcloning PCR fragments of JIP3. Expression vectors for MAPK,
MAPKK, MAPKKK, JIP1, and JIP2 were described previously (60, 70).
Antibodies. The antibodies to the Flag epitope tag (M2; Sigma), the hemag-
glutinin (HA) epitope tag (12CA5; Boehringer Mannheim), the T7-Tag epitope
tag (Novagen Inc.), glutathione S-transferase (GST; Pharmacia-LKB Biotech-
nology Inc.), and tubulin (Sigma Chemical Co.) were purchased from the indi-
cated supplier. Antibodies to JIP1 and JIP2 were described previously (70).
Antibodies to JIP3 were prepared by immunizing a rabbit with purified bacteri-
ally expressed JIP3b (residues 141 to 241), using standard techniques (19).
Cell culture. COS7 cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum in an incubator with
humidified air (5% CO2) at 37°C. The COS7 cells were transfected with plasmid
expression vectors by the Lipofectamine procedure (Life Technologies Inc.).
PC12 cells were cultured on collagen-coated plastic dishes in DMEM supple-
mented with 0.5 mM glutamine, 10% horse serum, and 5% fetal bovine serum
(Life Technologies Inc.) in a humidified incubator (10% CO2) at 37°C (64). The
cells were differentiated by incubation in DMEM supplemented with 1% horse
serum, 0.5 mM glutamine, and 50 ng of nerve growth factor (NGF) per ml (64).
The effect of NGF withdrawal was examined in cultures with neutralizing NGF
antibody and without NGF (64).
Biochemical assays. Cultured cells and mouse brain were solubilized in lysis
buffer (20 mM Tris-Cl [pH 7.4], 137 mM NaCl, 2 mM EDTA, 25 mM b-glycero-
phosphate, 2 mM pyrophosphate, 1 mM sodium orthovanadate, 1 mM phenyl-
methylsulfonyl fluoride, 10 mg of leupeptin per ml, 10% glycerol, 1% Triton
X-100). GST fusion proteins were isolated by incubation with glutathione-agar-
ose (Amersham Pharmacia Biotech Inc.) beads (20 ml) for 3 h at 4°C. Proteins
were immunoprecipitated by incubation for 3 h at 4°C with antibodies bound to
protein G-Sepharose (Amersham Pharmacia Biotech Inc.). Immunoblot analysis
was performed by enhanced chemiluminescence detection (Kirkegaard & Perry
Inc.). Binding assays using purified proteins were performed by methods de-
scribed previously (60, 70). The methods used for immune complex kinase assays,
phosphoamino acid analysis, and phosphopeptide mapping have also been de-
scribed elsewhere (17). The effect of scaffold proteins on MLK3-stimulated JNK
activity was examined in COS7 cell transfection assays using the in-gel method
with 0.25 mg of substrate (GST–c-Jun) per ml polymerized in the gel (60, 70).
Proteolytic digestion experiments were performed with purified recombinant
caspases (provided by S. Kharbanda, Dana-Farber Cancer Institute, Boston,
Mass.) and [35S]methionine-labeled in vitro-translated poly(ADP-ribose) poly-
merase (PARP) and JIP3b by incubation at 37°C for 30 min. The products of the
proteolytic digestion were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and detected by autoradiography.
Immunofluorescence analysis. PC12 cells were grown on glass coverslips
coated with laminin plus poly-D-lysine and differentiated in DMEM supple-
mented with 1% horse serum, 0.5 mM glutamine, and 50 ng of NGF per ml (64).
The cells were fixed by incubation (10 min) with 4% paraformaldehyde in
phosphate-buffered saline (PBS), washed with 10 mM glycine in PBS, and per-
meabilized with 0.2% Triton X-100 in PBS. After incubation (15 min) with 3%
(wt/vol) bovine serum albumin (BSA) in PBS, the coverslips were incubated (1 h)
with primary antibodies in PBS with 3% BSA. The primary antibodies were a
rabbit polyclonal antibody to JIP3, a rabbit polyclonal antibody to neuron-
specific enolase (Oncogene Research Products), and a mouse monoclonal anti-
body to tubulin (Sigma Chemical Co.). Immunocomplexes were detected with
Texas red-conjugated anti-rabbit immunoglobulin and fluorescein-conjugated
anti-mouse immunoglobulin secondary antibodies (Jackson ImmunoResearch
Inc.) in 3% BSA in PBS. The coverslips were mounted in Vectashield (Vector
Laboratories Inc.). Fluorescence microscopy was performed with a Zeiss Axio-
plan microscope.
Nucleotide sequence accession numbers. The sequences of JIP3a and JIP3b
have been deposited in GenBank with accession no. AF178636 and AF178637,
respectively.
RESULTS
Molecular cloning of JIP3. To identify novel proteins that
interact with JNK, we screened a mouse embryo cDNA library
by the two-hybrid method with JNK1 as the bait (7, 10). Two
clones isolated from the library that interacted with JNK1, but
not with ERK2, in the two-hybrid assay were found by se-
quence analysis to represent overlapping fragments corre-
sponding to a partial cDNA clone. We refer to the protein
encoded by this cDNA as JNK-interacting protein 3 (JIP3).
Two cDNA libraries were screened by plaque hybridization
to isolate full-length clones (Fig. 1). The largest clone isolated
from a mouse heart library (5,442 bp; JIP3a) and the largest
clone isolated from a mouse brain library (5,512 bp; JIP3b)
were each found to contain a single long open reading frame.
An in-frame termination codon was identified in the predicted
59 untranslated sequence, and a termination codon was iden-
tified prior to the predicted 39 untranslated region. Sequence
analysis demonstrated substantial identity between the JIP3a
and JIP3b cDNA clones, but there were significant differences
(Fig. 1b). JIP3b contains two insertions (18 and 27 bp) and a
single base pair change at codon 376. JIP3b is therefore larger
than JIP3a because of the two insertions (six and nine amino
acids). In addition, Phe376 (TTT) of JIP3a is replaced by Leu
(TTG) in JIP3b. It is likely that JIP3a and JIP3b are derived by
alternative splicing of transcripts derived from a single gene.
Computer-assisted sequence analysis of the JIP3 proteins
demonstrated the presence of an extended predicted coiled
coil domain in the NH2-terminal region (5). This region also
contained a predicted leucine zipper (29). These structural
features were conserved in JIP3a and JIP3b (Fig. 1). Analysis
of the GenBank database indicated four entries describing
sequences similar to JIP3. One partial human cDNA (acces-
sion no. AB028989) encodes a predicted protein that is very
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similar to the COOH-terminal region of murine JIP3 and may
represent a fragment of human JIP3 (55). A second partial
human cDNA (accession no. AB011088) also encodes a pro-
tein with similarity to the COOH-terminal region of JIP3, but
this protein is the product of a distinct gene (55) and may be a
related member of the JIP3 group (JIP3b). A more distantly
related human sequence with similarity to JIP3 (accession no.
X91879) may correspond to a third member of a JIP3 gene
family (JIP3g) (50). A fourth sequence related to JIP3 in the
database corresponds to a predicted protein encoded by the C.
elegans genome and may be a nematode member of the JIP3
group of proteins (hypothetical protein ZK1098.10). No func-
tional analysis of these JIP3-related sequences has been re-
ported.
Expression of JIP3 in murine tissues. We examined the
expression of JIP3 in different murine tissues by Northern blot
analysis (Fig. 1C). The largest amount of JIP3 mRNA (approx-
imately 6 kb) expression was detected in the brain, with lower
levels in the heart and other tissues. To confirm this pattern of
JIP3 expression, we prepared a rabbit polyclonal antibody by
using recombinant JIP3 as an antigen and examined expression
of the JIP3 protein in different tissues by Western blot analysis
(Fig. 1D). A high level of JIP3 expression in the brain was
detected. In addition, expression of the JIP3 protein was found
in the heart and lung. A low level of JIP3 expression was
detected in other tissues.
The highest amount of JIP3 expression was detected in the
brain (Fig. 1C and D). To test whether the expression of JIP3
in the brain was restricted to a subregion of the brain, we
examined the expression of JIP3 by immunoblot analysis of
protein extracts prepared from subregions of mouse brain.
This analysis demonstrated that the JIP3 protein was widely
expressed throughout many regions of the murine brain (Fig.
1D).
JIP3 selectively binds to the JNK group of MAPKs. JIP3 was
isolated in a two-hybrid screen using JNK as the bait. This
result suggests that JIP3 may bind JNK. To test this hypothesis,
we expressed JIP3 and JNK in COS7 cells and examined the
interaction of these proteins by coprecipitation analysis (Fig.
2A). We found that JNK coprecipitated with JIP3 (Fig. 2A)
and that JIP3 coprecipitated with JNK (Fig. 2B). However, no
coprecipitation of JIP3 with ERK or p38 MAPKs was detected
(Fig. 2A).
Interestingly, we found that the extent of coprecipitation of
JIP3 was greater in assays using JNK3 than in assays using
JNK1 or JNK2. This difference suggests that JIP3 may selec-
tively bind JNK isoforms. We therefore tested the interaction
of all 10 known JNK protein kinase isoforms with JIP3 in vitro
(Fig. 2C). No binding of JNK to recombinant GST was ob-
served. However, JNK binding to recombinant GST-JIP3 was
detected. Quantitation of the extent of binding demonstrated
that increased binding was observed for JNK1b and JNK3a
isoforms compared to other JNK isoforms (Fig. 2C). These
data indicate that while JIP3 does exhibit some selectivity in
binding to JNK isoforms, JIP3 is able to bind all JNK isoforms.
Comparison of the two partial cDNA clones isolated from
the two-hybrid screen indicated an overlapping region that
encoded JIP3 residues 141 to 241. To test whether this region
binds to JNK, we expressed this fragment of JIP3 as a GST
fusion protein in bacteria. The GST-JIP3 protein was purified,
immobilized on glutathione-agarose beads, and incubated with
COS7 cell extracts. The agarose beads were washed, and the
bound JNK was detected by immunoblot analysis. It was found
that this JIP3 fragment bound JNK (Fig. 2D). To further de-
fine the region that is required for interaction with JNK, we
constructed a deletion series by removal of NH2- and COOH-
FIG. 1. Structure and expression of JIP3. (A) Structure of JIP3 illustrated
schematically. (B) Primary sequence of mouse JIP3a and JIP3b deduced from
the sequence of cDNA clones, presented in single-letter code. Numbering is
based on the sequence of JIP3b. Residues identical to those in JIP3a (.), dele-
tions (-), and termination codons (#) are indicated. (C) Expression of JIP3
mRNA, examined by Northern blot analysis of 2 mg of poly(A)1 mRNA isolated
from different murine tissues (Clontech Inc.), using a 1.3-kb EcoRI/XbaI frag-
ment of the JIP3a cDNA as a probe (inset). RNA size markers (in kilobases) are
indicated on the left. Expression of JIP3 mRNA in different mouse tissues was
also examined by dot blot analysis of 5 mg of total RNA hybridized to the JIP3a
probe and was quantitated with a PhosphorImager (Molecular Dynamics Inc.).
The data are presented graphically as the amount of expression relative to whole
brain (100%). Sk, skeletal; Sm, smooth; Submax., submaxillary. (D) Expression
of JIP3 protein, examined by Western blot analysis of 75 mg of total protein
isolated from different murine tissues and brain subregions (Geno Technology
Inc.), using a polyclonal antibody to JIP3. Protein size markers are indicated on
the left.
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terminal amino acid residues. Binding assays demonstrated
that the region surrounding JIP3 residues 207 to 216 was re-
quired for interaction with JNK (Fig. 2D).
To further define the JNK binding domain of JIP3, we ex-
amined the effect of point mutations within the predicted JNK
binding domain. These experiments were performed by com-
petition analysis (10) using synthetic peptides corresponding to
the JIP3 predicted JNK binding domain. Binding assays were
performed with JNK and immobilized recombinant GST-JIP3
(Fig. 2E). Addition of the synthetic peptide Arg202-Lys-Glu-
FIG. 2. JIP3 binds to the JNK group of MAPKs. (A) Interaction of JIP3 with MAPKs, examined by expression of GST-JIP3a and HA epitope-tagged MAPKs in
COS7 cells. GST-JIP3a was isolated from cell lysates by incubation with glutathione-agarose beads and was detected by immunoblot analysis using an antibody that
binds GST. The binding to MAPKs was examined by immunoblot analysis using an antibody that binds the HA epitope tag. The interaction of JIP3 with JNK1a1,
JNK2a2, JNK3a2, p38a, and ERK2 was investigated. Control experiments were performed by transfection of an empty expression vector instead of the MAPK
expression vectors. (B) Epitope-tagged T7-JIP3a and HA-JNK1 were expressed in COS7 cells. Lysates were prepared, and the amount of JIP3 and JNK1 was examined
by immunoblot analysis using monoclonal antibodies to the T7 and HA epitopes. HA-JNK1 was immunoprecipitated with the HA antibody, and T7-JIP3a in the
immunoprecipitates was detected by immunoblot analysis with an antibody to the T7 epitope tag. (C) Comparison of the binding of 10 JNK isoforms to JIP3. GST and
GST-JIP3a were expressed in COS7 cells and immobilized on glutathione-agarose beads. The JNK MAPKs were prepared by in vitro translation in the presence of
[35S]methionine and incubated with immobilized GST and GST-JIP3a. No interaction of JNK with GST was detected. However, the JNK protein kinases bound to
GST-JIP3a. The bound JNK was detected by SDS-PAGE and autoradiography. The radioactivity was quantitated by PhosphorImager analysis (Molecular Dynamics)
and is presented graphically as relative binding. (D) Deletion analysis of JIP3. A series of GST-JIP3b fragments were expressed in bacteria, purified, and immobilized
on glutathione-agarose beads. The interaction of these JIP3b fragments with JNK was examined by incubation of the immobilized JIP3b proteins with lysates prepared
from COS7 cells expressing Flag epitope-tagged JNK1a1. Bound JNK was detected by immunoblot analysis using antibody M2, which binds the Flag epitope tag. (E)
Mutational analysis of the JNK binding domain of JIP3. The function of the JNK binding domain was examined in binding assays using immobilized GST (lane 1) or
GST-JIP3b (residues 141 to 241) (lanes 2 to 13) and Flag epitope-tagged JNK1a1 (lane 14). Competition assays were performed by including in the binding assay a
synthetic peptide corresponding to the JNK binding domain (10 mg/ml) (lane 3). The effect of replacement of residues in the JNK binding domain with Gly was
examined (lanes 4 to 13). The binding of JNK to the immobilized GST-JIP3b is presented. (F) Primary sequences of the JNK binding domains of JIP3 and JIP1 and
the consensus sequence.
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Arg-Pro-Thr-Ser-Leu-Asn-Val-Phe-Pro213 caused a dose-de-
pendent inhibition of JNK binding to GST-JIP3 (data not
shown). Complete inhibition of JNK binding was observed in
the presence of 10 mg of synthetic peptide per ml (Fig. 2E).
Analysis of competitive binding assays using mutated synthetic
peptides containing a Gly substitution indicated that JIP3 res-
idues Arg205, Pro206, Thr207, Ser208, and Leu209 were important
for interaction with JNK. Interestingly, this region of JIP3
shows primary sequence identity to the JNK binding domain of
JIP1 (10). Alignment of the JNK binding domains of JIP3 and
JIP1 indicated significant sequence identity (Fig. 2F).
JIP3 is phosphorylated by JNK in vitro and in vivo. The
interaction between JNK and JIP3 suggests that JIP3 may be a
JNK substrate. To test this hypothesis, we performed in vitro
protein kinase assays using purified bacterially expressed JIP3
(Fig. 3A). These experiments demonstrated that JIP3 was
phosphorylated by JNK. Control experiments demonstrated
that JIP3 was not phosphorylated by kinase-inactive JNK (data
not shown). The extent of JIP3 phosphorylation by JNK was
similar to that of a known JNK substrate, ATF2 (17, 31).
Control experiments demonstrated that JIP3 was not phos-
phorylated by the related MAPKs ERK2 and p38a.
Examination of the primary sequence of JIP3 indicates three
potential JNK phosphorylation sites (Ser/Thr-Pro): Thr266,
Thr276, and Thr287. To test whether these residues are sites of
JNK phosphorylation, we investigated the effect of point mu-
tations at each of these sites (Fig. 3B). Replacement of each
Thr residue with Ala did not markedly decrease the phosphor-
ylation of JIP3 by JNK. However, the simultaneous replace-
ment of all three Thr residues with Ala caused a large decrease
in phosphorylation. Phosphoamino acid analysis confirmed
that JNK caused Thr phosphorylation of JIP3 (Fig. 3C). This
phosphorylation on Thr was markedly decreased when Thr266,
Thr276, and Thr287 were replaced with Ala. These data indicate
FIG. 3. JIP3 is phosphorylated by JNK in vivo and in vitro. (A) JIP3 is phosphorylated by JNK in vitro. Epitope-tagged JNK1a1, p38a, and ERK2 MAPKs were
expressed in COS-7 cells. The JNK and p38 MAPKs were activated by treatment of the cells without (2) and with (1) UV-C radiation (80 J/m2). The ERK MAPK
was activated by treatment of the cells without (2) and with (1) 100 nM phorbol myristate acetate. The MAPKs were isolated by immunoprecipitation using a
monoclonal antibody to the HA epitope tag, and immunocomplex protein kinase assays were performed with [g-32P]ATP and GST-JIP3b (residues 190 to 380) as the
substrate. Control experiments were performed with known substrates for JNK (GST-ATF2), p38 (GST-ATF2), and ERK (GST–c-Myc). Phosphorylation of the
substrate proteins was detected following SDS-PAGE by autoradiography. Phosphorylation of JIP3b by JNK, but not by p38 or ERK, was observed. (B and C)
Mutational analysis of JIP3b phosphorylation by JNK. Three potential JNK phosphorylation sites (Ser/Thr-Pro) were identified by sequence analysis (Thr266, Thr276,
and Thr287). These potential phosphorylation sites were replaced with Ala residues, and the wild-type and mutated JIP3b proteins were examined as substrates for JNK
in vitro. The phosphorylation of these JIP3b proteins was detected following SDS-PAGE by autoradiography (B) and was also examined by phosphoamino acid analysis
(C). (D) JNK activation in vivo decreases the electrophoretic mobility of JIP3. Flag epitope-tagged JIP3b was expressed in COS7 cells and was detected by immunoblot
analysis using antibody M2. The cells were treated without (2) and with (1) UV-C radiation (80 J/m2) to activate JNK. The effect of replacement of the JNK
phosphorylation sites Thr266, Thr276, and Thr287 with Ala (Thr/Ala) was examined. (E) COS7 cells expressing epitope-tagged wild-type and mutated [Ala266, Ala276,
Ala287] JIP3b were metabolically labeled with [32P]phosphate. The phosphorylated JIP3b proteins were detected following immunoprecipitation and SDS-PAGE by
autoradiography (left) and were examined by phosphoamino acid analysis (right). (F) Analysis of JIP3 phosphorylation by phosphopeptide mapping. Wild-type and
mutated (Thr/Ala) [Ala266, Ala276, Ala287] JIP3b phosphorylated in vivo were investigated by phosphopeptide mapping. Maps of JIP3 phosphorylated by JNK1 in vitro
were also examined. Comparative phosphopeptide maps were prepared by mixing equal amounts of radioactivity derived from wild-type JIP3 phosphorylated in vivo
and in vitro. The origin (o) is indicated on the right. The horizontal and vertical dimensions are electrophoresis and chromatography, respectively. The major
[32P]phosphopeptide present in maps of in vivo phosphorylated wild-type JIP3b and absent in maps of mutated (Thr/Ala) JIP3b is indicated with an arrow.
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that JNK phosphorylated JIP3 on Thr266, Thr276, and Thr287 in
vitro.
To test whether JIP3 was phosphorylated by JNK in vivo, we
investigated the effect of JNK activation on the electrophoretic
mobility of JIP3 by Western blot analysis (Fig. 3D). Exposure
of cells to UV-C radiation caused a marked decrease in JIP3
mobility. In contrast, no decrease in JIP3 mobility following
exposure to UV radiation was detected when the three sites of
in vitro phosphorylation by JNK (Thr266, Thr276, and Thr287)
were replaced with Ala. The effect of these point mutations to
eliminate the UV radiation-stimulated electrophoretic mobil-
ity shift is consistent with the hypothesis that JNK phosphor-
ylates JIP3 in vivo.
To examine JIP3 phosphorylation by more direct biochem-
ical methods, we isolated JIP3 from cells metabolically labeled
with [32P]phosphate (Fig. 3E). This metabolic labeling proce-
dure causes JNK activation, most likely as a consequence of
the exposure of the cells to high levels of ionizing radiation.
Phosphoamino acid analysis demonstrated that JIP3 was phos-
phorylated extensively on Ser residues. No Tyr phosphoryla-
tion was detected, but JIP3 phosphorylation on Thr was ob-
served. Replacement of Thr266, Thr276, and Thr287 with Ala
residues caused decreased Thr phosphorylation of JIP3 in vivo.
Comparative tryptic phosphopeptide mapping demonstrated
that wild-type JIP3 contained a phosphopeptide that was ab-
sent in maps of the mutated JIP3 protein (Fig. 3F). This phos-
phopeptide comigrated with a major phosphopeptide observed
in maps of JIP3 phosphorylated by JNK in vitro. Together,
these data establish that JIP3 is phosphorylated in vivo on sites
phosphorylated by JNK in vitro.
JIP3 binds to the MAPKK MKK7 and the MAPKKK
MLK3. We have reported that JIP1 and JIP2 interact with
several components of the JNK signaling pathway, including
the JNK protein kinases (60, 70). Since JIP3 binds to JNK (Fig.
2), we tested whether JIP3, like the JIP1 and JIP2 proteins,
might also interact with other components of the JNK signal-
ing pathway.
The interaction of JIP3 with MAPKK was investigated by
coprecipitation analysis (Fig. 4A). These experiments demon-
strated that the JNK activator MKK7 coprecipitated with JIP3
(Fig. 4A) and that JIP3 coprecipitated with MKK7 (Fig. 4B).
In contrast, no interaction between JIP3 and the JNK activator
MKK4 was detected. Similarly, no binding of JIP3 to the p38
MAPK activators MKK3 and MKK6 or the ERK activator
MEK1 was observed. These data indicate that JIP3 selectively
interacts with MKK7 and not with other members of the
MAPKK group of protein kinases (Fig. 4A). Binding assays
performed with purified recombinant proteins demonstrated
that MKK7 directly interacts with JIP3 (Fig. 4C). Deletion
analysis of JIP3 demonstrated that the central region of the
molecule (residues 410 to 815) bound strongly to MKK7 (Fig.
4D). A weak interaction between the NH2-terminal region of
JIP3 (residues 1 to 442) and MKK7 was also detected (Fig.
4D). The central region of JIP3 that strongly binds MKK7
(residues 410 to 815) is distinct from the JNK binding domain
located within the NH2-terminal region of JIP3 (residues 205
to 209 [Fig. 2]). The primary site of JIP3 interaction with
MKK7 is therefore different from the site of JIP3 interaction
with JNK.
Coprecipitation assays were performed to examine the in-
teraction of MAPKKK with JIP3. No interaction of JIP3 with
c-Raf, MEKK1, MEKK4, DLK, MLK2, or ASK1 was observed
(Fig. 5A). However, MLK3 was found to coprecipitate with
JIP3 (Fig. 5A), and JIP3 was found to coprecipitate with
MLK3 (Fig. 5B). Thus, JIP3 appears to interact selectively with
MLK3 and not with other members of the MAPKKK group of
protein kinases. Binding assays performed with purified recom-
binant proteins demonstrated that MLK3 directly interacts
with JIP3 (Fig. 5C). Deletion analysis of JIP3 indicated that the
COOH-terminal region JIP3 (residues 800 to 1337) did not
bind MLK3 (Fig. 5D). However, MLK3 binding to the NH2-
terminal region of JIP3 was observed (residues 1 to 815).
Deletions within this NH2-terminal region indicated strong
binding to JIP3 residues 1 to 442, but weak binding of MLK3
was also detected in experiments using JIP3 residues 420 to
815.
Together, these data demonstrate that JIP3 interacts with
proteins that can form a MAPK signaling module, including
JNK, MKK7, and MLK3.
JNK activation increases complex formation with JIP3. JNK
binding to JIP3 was detected in experiments using purified
recombinant proteins and in transfection assays using overex-
pressed recombinant proteins (Fig. 2). These observations sug-
gested that endogenous JNK and JIP3 may form complexes in
FIG. 4. JIP3 binds to the MAPKK MKK7. (A) JIP3a was expressed as a GST
fusion protein in COS7 cells together with epitope-tagged MEK1, MKK3,
MKK4, MKK6, and MKK7. Control experiments were performed with an empty
vector instead of the MAPKK expression vector. The expression of JIP3a and
MAPKK was examined by immunoblot analysis of cell lysates. GST-JIP3a was
isolated on glutathione-agarose beads, and the bound MAPKKs were detected
by immunoblot analysis. (B) Epitope-tagged T7-JIP3a and Flag-MKK7 were
expressed in COS-7 cells. Lysates were prepared, and the amount of JIP3 and
MKK7 was examined by immunoblot analysis using monoclonal antibodies to the
T7 and Flag epitopes. The Flag-MKK7 was immunoprecipitated with antibody
M2, and T7-JIP3a in the immunoprecipitates was detected by immunoblot anal-
ysis with an antibody to the T7 epitope tag. (C) Purified recombinant GST and
GST-JIP3a were immobilized on glutathione-agarose and incubated with puri-
fied recombinant Flag-tagged MKK7. Bound MKK7 was detected by immuno-
blot analysis using an antibody that binds the Flag epitope tag. (D) Deletion
analysis of JIP3. To define the MKK7 binding region of JIP3, in vitro-translated
fragments of JIP3a (residues 1 to 442, 410 to 815, and 800 to 1337) were prepared
in the presence of [35S]methionine. Control experiments were performed with in
vitro-translated luciferase. These proteins were incubated with GST or GST-
MKK7 immobilized on glutathione-agarose. The binding of JIP3 was detected
following SDS-PAGE by autoradiography. Binding of in vitro-translated JIP3 to
GST-MKK7, but not to GST, was detected.
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cells. To test this hypothesis, we prepared soluble extracts from
mouse brain and performed coimmunoprecipitation analysis.
This analysis confirmed that endogenous JIP3 forms com-
plexes with JNK and MKK7 (Fig. 6A).
The complexes formed between JNK and JIP3 might be
regulated by activation of the JNK signaling pathway. We
therefore examined the effect of JNK activation (caused by
UV-C radiation) on the coimmunoprecipitation of JNK and
JIP3 (Fig. 6B). JNK activation was found to markedly increase
the coimmunoprecipitation of JIP3 with endogenous JNK.
These data indicated that JNK activation is associated with
increased formation of JIP3 complexes with JNK. Since JIP3 is
a JNK substrate, it was possible that this increased complex
formation was related to changes in JIP3 phosphorylation. To
test this hypothesis, we examined the effect of replacement of
the three sites of JNK phosphorylation on JIP3 (Thr266, Thr276,
and Thr287) with Ala. The wild-type and phosphorylation-de-
fective JIP3 proteins were found to form similar complexes
with JNK (Fig. 6B). The phosphorylation of JIP3 by JNK
therefore does not contribute to the regulated formation of
JNK complexes with JIP3.
Together, these data demonstrate that JNK activation aug-
ments the formation of JNK complexes with JIP3.
JIP3 increases MLK3-stimulated JNK activity. The interac-
tion of JIP3 with JNK, MKK7, and MLK3 protein kinases
suggested that JIP3 may act as a molecular scaffold for a JNK
signaling module. If JIP3 serves this function, we would expect
the expression of JIP3 to increase the activation of JNK caused
by MLK3. To test this hypothesis, we performed transfection
assays using COS7 cells, which do not express JIP3 (data not
shown) or the putative scaffold proteins JIP1 and JIP2 (60, 70).
JNK activity was measured with c-Jun as the substrate (Fig. 7).
Expression of JIP3 did not cause JNK activation. However,
JIP3 increased the activation of JNK caused by MLK3. Similar
results were obtained in experiments using JNK1, JNK2, and
JNK3. The effect of JIP3 to potentiate MLK3-stimulated JNK
activation was similar to that caused by the putative scaffold
proteins JIP1 and JIP2 (Fig. 7). It was also found that both
JIP1a and JIP1b caused potentiation of MLK3-stimulated JNK
activation (data not shown). These data indicated that JIP3
might be a mammalian MAPK scaffold protein for a JNK
signaling module.
To examine the role of JIP3 phosphorylation during MLK3-
stimulated JNK activation, we compared the effect of wild-type
JIP3b and the phosphorylation-defective [Ala266, Ala276,
Ala287] JIP3b protein that lacks the three sites of phosphory-
lation by JNK. We found that the wild-type and mutated JIP3b
proteins caused similar potentiation of MLK3-stimulated JNK
activation (data not shown). The phosphorylation of JIP3 by
JNK therefore does not appear to contribute to JNK regula-
tion.
JIP3 selectively interacts with JNK MAPK scaffold proteins.
The JIP1 and JIP2 scaffold proteins appear to function as
oligomeric complexes formed from dimers or higher-order ag-
gregates (70). We therefore examined whether JIP3 might also
form oligomeric complexes (Fig. 8). T7 epitope-tagged and
GST-tagged JIP3a proteins were expressed in COS7 cells.
GST-JIP3 was isolated with glutathione-agarose, and the bind-
ing of T7-tagged JIP3 was examined by immunoblot analysis.
The JIP3 proteins were found to coprecipitate (Fig. 8A). These
FIG. 5. Interaction of JIP3 with MAPKKK. (A) Epitope-tagged MAPKKKs and GST-JIP3a were expressed in COS7 cells. Control experiments were performed
with empty vector instead of the MAPKKK expression vectors. GST-JIP3a protein was isolated on glutathione-agarose beads. The binding of MAPKKK to JIP3 was
examined by immunoblot analysis using an antibody that binds the epitope tag. (B) Epitope-tagged T7-JIP3a and HA-MLK3 were expressed in COS7 cells. Lysates
were prepared, and the amount of JIP3a and MLK3 was examined by immunoblot analysis using monoclonal antibodies to the T7 and HA epitopes. HA-MLK3 was
immunoprecipitated with the HA antibody, and T7-JIP3a in the immunoprecipitates was detected by immunoblot analysis with an antibody to the T7 epitope tag. (C)
Interaction of purified recombinant MLK3 with JIP3a. Epitope-tagged HA-MLK3 was isolated by immunoprecipitation and was eluted by incubation with HA synthetic
peptide (20 mg/ml) for 2 h at 4°C. The purified soluble MLK3 was incubated with GST or GST-JIP3a immobilized on glutathione-agarose. The amount of MLK3, GST,
and GST-JIP3a was examined by immunoblot analysis using HA or GST antibodies. The agarose beads were washed, and bound MLK3 was detected by immunoblot
analysis with an antibody to the HA epitope tag. (D) Deletion analysis of JIP3. To define the MLK3 binding region of JIP3, fragments of JIP3a (residues 1 to 1337,
1 to 815, 1 to 442, 420 to 815, and 800 to 1337) fused to GST were immobilized on glutathione-agarose. Control experiments were performed with immobilized GST.
These immobilized proteins were incubated with MLK3 (top) or luciferase (bottom) prepared by in vitro translation in the presence of [35S]methionine. Binding to the
immobilized proteins was examined following SDS-PAGE by autoradiography.
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data indicated that JIP3 forms oligomeric complexes (either
dimers or higher-order oligomeric complexes). Deletion anal-
ysis indicated that the NH2-terminal region (residues 1 to 442)
of JIP3 was sufficient for this interaction (data not shown). This
region includes the extended predicted coiled coil domain,
which may therefore mediate JIP3-JIP3 association.
We also tested whether JIP3 interacted with the JIP1 and
JIP2 scaffold complexes. We expressed T7-tagged JIP1, T7-
tagged JIP2, and GST-tagged JIP3a in COS7 cells. The GST-
JIP3 was isolated on glutathione-agarose, and the binding of
JIP1 and JIP2 proteins to JIP3 was examined by immunoblot
analysis. We found that JIP2 (but not JIP1) coprecipitated with
JIP3 (Fig. 8B) and that JIP3 coprecipitated with JIP2 (Fig. 8C).
Deletion analysis demonstrated that the central region of JIP3
(residues 420 to 815) (Fig. 8D) and the COOH-terminal region
of JIP2 (residues 557 to 824) (Fig. 8E) were required for this
interaction. These data demonstrate that JIP3 can form com-
plexes with the JIP2 scaffold protein. However, complex for-
mation with JIP2 was not required for the effect of JIP3 to
increase MLK3-stimulated JNK activity (Fig. 7) since COS7
cells do not express JIP2 (70).
To test whether complexes are formed between endogenous
JIP3 and JIP2, we performed coimmunoprecipitation assays
using mouse brain. We found that JIP2 coimmunoprecipitated
with JIP3 (Fig. 6A). In addition, a low level of JIP1 was found
to coprecipitate with JIP3. Since recombinant JIP1 and JIP3
did not interact (Fig. 8B) and heterodimeric complexes are
formed between JIP1 and JIP2 (70), the low level of copre-
cipitation of endogenous JIP1 with JIP3 (Fig. 6A) may reflect
the interaction of JIP3 with a JIP1-JIP2 heterodimer.
These data demonstrate that different complexes can be
formed by the association of various members of the JIP group
of scaffold proteins.
NGF regulates the expression of JIP3. The observation that
a greater amount of JIP3 was detected in the brain than in
other tissues (Fig. 1) suggested that JIP3 expression might be
induced during neuronal differentiation. To test this hypothe-
sis, we investigated the expression of JIP3 in the PC12 cell
model of neuronal differentiation in response to NGF (Fig.
9A). Western blot analysis demonstrated that JIP3 was not
FIG. 6. Identification of JIP3 complexes. (A) The interaction of JIP3 with
components of the JNK signaling pathway was examined by coimmunoprecipi-
tation analysis. Soluble extracts prepared from mouse brain were immunopre-
cipitated with a nonimmune antibody (Control) and with antibodies to JNK,
MKK7, JIP1, and JIP2. The immunoprecipitates were examined by immunoblot
analysis with an antibody to JIP3. (B) Complex formation with JIP3 is increased
by JNK activation. COS cells were transfected with an empty expression vector
(Control) or with an expression vector for Flag-tagged JIP3b. The effect of
replacement of the three JNK phosphorylation sites (Thr266, Thr276, and Thr287)
with Ala was examined. The cells were exposed without (2) and with (1) UV-C
radiation (80 J/m2) and incubated for 1 h. JIP3b was isolated by immunopre-
cipitation with monoclonal antibody M2. The presence of JNK in the immuno-
precipitates was examined by immunoblot analysis by probing with a rabbit
polyclonal antibody to JNK.
FIG. 7. JIP3 potentiates MLK3-stimulated JNK activity. The effect of JIP3 on MLK3-stimulated JNK activity was examined in cotransfection assays using HA
epitope-tagged JNK1a1 (A), JNK2a2 (B), and JNK3a2 (C). The effect of expression of MLK3 and JIP3a was examined. Control experiments were performed with the
JIP1 and JIP2 scaffold proteins. The expression of MLK3, JIP1, JIP2, JIP3, and JNK was investigated by immunoblot analysis. JNK was immunoprecipitated with an
antibody that binds the HA epitope tag, and protein kinase activity was measured with [g-32P]ATP and c-Jun as substrates. The phosphorylated c-Jun was detected
following SDS-PAGE by autoradiography and was quantitated by PhosphorImager (Molecular Dynamics) analysis. The data presented were derived from one
experiment. Similar data were obtained in seven independent experiments.
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detected in proliferating PC12 cells, but JIP3 expression was
observed in differentiated PC12 cells. Time course analysis
indicated that JIP3 expression was not an early event following
NGF treatment (Fig. 9B). However, JIP3 expression was de-
tected at 5 days following initiation of NGF-stimulated differ-
entiation.
The observation that NGF induced the expression of JIP3
raises questions about what might happen to JIP3 when NGF
is withdrawn from NGF-differentiated PC12 cells. Western
blot analysis demonstrated that the amount of JIP3 protein was
markedly decreased when NGF was withdrawn from differen-
tiated PC12 cells (Fig. 9C). Interestingly, NGF withdrawal
caused an increase in the amount of lower-molecular-weight
immunoreactive JIP3-related proteins. A plausible hypothesis
was that NGF withdrawal, which causes caspase activation and
apoptosis, results in the proteolytic cleavage of JIP3. To test
this hypothesis, we examined the effect of the caspase inhibitor
zVAD following NGF withdrawal. This analysis demonstrated
that caspase inhibition prevented the loss of JIP3 protein
caused by NGF withdrawal (Fig. 9C).
To investigate whether JIP3 was a caspase substrate, we
performed in vitro assays using purified caspases (Fig. 9D).
These experiments demonstrated that JIP3 was a substrate for
caspase 3, but not caspase 1. Control experiments were per-
formed using PARP, a known caspase 3 substrate (57). Addi-
tion of either the general caspase inhibitor zVAD or the more
selective caspase 3 inhibitor DEVD to the in vitro assay
blocked the cleavage of JIP3 caused by caspase 3 (Fig. 9E).
Previous studies have established a consensus sequence (Asp-
Xaa-Xaa-Asp) for substrate cleavage by caspase 3 (46). Exam-
ination of the primary sequence of JIP3 indicated three poten-
tial caspase 3 cleavage sites. Two of these sites were located
very close to the COOH terminus of JIP3. Cleavage at either
of these sites would cause a small decrease in the mass of JIP3
but would not account for the observed fragmentation of JIP3
observed in vivo (Fig. 9C) or in vitro (Fig. 9D). In contrast, a
third site located in the central region of JIP3 may contribute
to the observed proteolysis. To test this hypothesis, we re-
placed Asp344 with Glu to remove this potential site of caspase
3 cleavage. This mutation caused a marked decrease in the
proteolysis of JIP3 caused by purified caspase 3 in vitro (Fig.
9F).
Together, these data indicate that the expression of JIP3 is
induced during NGF-stimulated neuronal differentiation and
that JIP3 is down-regulated, in part, by caspase-mediated
cleavage during NGF withdrawal-induced apoptosis.
Subcellular localization of JIP3. We investigated the sub-
cellular distribution of JIP3 in NGF-differentiated PC12 cells
by immunofluorescence analysis (Fig. 10). The specificity of
the immunofluorescence observed was confirmed in control
experiments which demonstrated that the intensity of JIP3
staining was reduced when recombinant JIP3 was included as
a competitor during the incubation with primary antibodies.
Two regions of the PC12 cells stained with antibodies to JIP3.
First, we observed JIP3 immunofluorescence in the soma, with
strong staining of the cytoplasmic compartment. Second, JIP3
immunofluorescence was detected at the end of the developing
neurites that projected from the soma. Double-label immuno-
fluorescence analysis with tubulin antibodies demonstrated
that JIP3 was localized in the growth cone of the neurites. This
localization might represent a preferential accumulation of
JIP3 in the growth cone, but it was also possible that the
apparent growth cone localization was an indirect consequence
of cytoplasmic volume rather than specific localization. We
therefore compared the immunofluorescence pattern of JIP3
with that of neuron-specific enolase. In contrast to JIP3 anti-
bodies, which stain the soma and the growth cones, neuron-
specific enolase antibodies were found to stain both the soma
and the neurites. These data indicate that the growth cone
localization of JIP3 represents compartmentalization rather
than a nonspecific consequence of cytoplasmic volume.
The localization of JIP3 in the soma and the growth cones of
differentiated PC12 cells suggests that these cell compartments
may represent sites where JIP3 exerts its physiological func-
tions within the cell.
DISCUSSION
MAPKinase scaffold complexes. MAPK signaling modules
function to regulate MAPK activation. The minimal elements
of a module include a MAPKKK, a MAPKK, and a MAPK.
These three protein kinases function together to form a sig-
naling cascade. The interactions between these protein kinases
FIG. 8. JIP3 selectively interacts with JIP scaffold proteins. (A) Epitope
(T7)-tagged JIP3a was coexpressed with GST-tagged JIP3a in COS7 cells and
incubated with glutathione-agarose. Bound proteins were detected by immuno-
blot analysis with an antibody to the T7 epitope. Expression of T7-JIP3 and
GST-JIP3 proteins in the cell lysates was examined by immunoblot analysis. (B)
Epitope (T7)-tagged JIP1 and JIP2 were expressed in COS7 cells. JIP3a was also
expressed as a GST fusion protein in COS7 cells and immobilized on glutathi-
one-agarose beads. Bound proteins were detected by immunoblot analysis with
an antibody to the T7 epitope. Expression of T7-JIP1, T7-JIP2, and GST-JIP3a
proteins in the cell lysates was monitored by immunoblot analysis. (C) Epitope-
tagged T7-JIP3a and Flag-JIP2 were expressed in COS-7 cells. Lysates were
prepared, and the amount of JIP3 and JIP2 was examined by immunoblot
analysis using monoclonal antibodies to the T7 and Flag epitopes. The Flag-JIP2
was immunoprecipitated with antibody M2, and T7-JIP3 in the immunoprecipi-
tates was detected by immunoblot analysis with an antibody to the T7 epitope
tag. (D) Deletion analysis of JIP3. To define the JIP2 binding region of JIP3a,
fragments of JIP3a (residues 1 to 1337, 1 to 815, 1 to 442, 420 to 815, and 800 to
1337) fused to GST were immobilized on glutathione-agarose. Control experi-
ments were performed with immobilized GST. These immobilized proteins were
incubated with JIP2 prepared by in vitro translation in the presence of [35S]me-
thionine. Binding of JIP2 to the immobilized proteins was examined following
SDS-PAGE by autoradiography. (E) Deletion analysis of JIP2. To define the
JIP3 binding region of JIP2, fragments of JIP2 fused to GST were immobilized
on glutathione-agarose. Control experiments were performed with GST. These
immobilized proteins were incubated with JIP3a prepared by in vitro translation
in the presence of [35S]methionine. The binding of JIP3 to an NH2-terminal
fragment of JIP2 (residues 1 to 229) and a COOH-terminal fragment of JIP2
(residues 557 to 824) was examined following SDS-PAGE by autoradiography.
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may involve sequential binary complexes between MAPKK
and MAPKKK or MAPK (3, 63). It is also possible that larger
complexes involving components of the MAPK module func-
tion to transmit signals through the protein kinase cascade
(61). It is likely that both of these mechanisms are utilized by
MAPK signaling pathways in response to extracellular stimu-
lation. The mechanism that is used most likely depends upon
the specific MAPK pathway and the nature of the extracellular
stimulus. Two types of multicomponent complexes involving a
MAPK signaling module have been identified.
(i) These complexes may be coordinated by a component of
the MAPK module. For example, the MAPKK Pbs2p in yeast
can create an osmoregulatory MAPK module through interac-
tions with both the MAPKKK Ste11p and the MAPK Hog1p
(38). A second example is provided by the observation that the
mammalian MAPKKK MEKK1 binds to JNK, MKK4, and the
Ste20-related protein kinase NIK (54, 63, 65). These interac-
tions may participate in the transmission of signals from
MEKK1 to JNK by the creation of a specific signaling module
in vivo (61).
(ii) Complex formation by a MAPK module can also be
coordinated by the interactions of the components of a MAPK
module with other proteins that serve as a scaffold for the
assembly of a functional signaling module. The best example of
such a scaffold protein is Ste5p (12). The Ste5p scaffold protein
is required for the activation of the mating MAPKinase path-
way in yeast and appears to bind multiple components of the
signaling module, including the MAPK Fus3p, the MAPKK
Ste7p, and the MAPKKK Ste11p (6, 34, 39). Detailed genetic
and biochemical studies establish that Ste5p organizes the
MAPK signaling module that regulates mating (12). Scaffold
proteins that are structurally similar to Ste5p have not been
identified in mammals. However, putative scaffold proteins
that may function to regulate mammalian MAPK signaling
modules have been reported. Studies of the ERK MAPK path-
way have led to the molecular cloning of MP1, a putative
scaffold protein that binds both the MAPK ERK1 and the
MAPKK MEK1 (48). Transfection assays indicate that MP1
potentiates the activation of ERK1 by MEK1 and may function
as a scaffold protein in vivo. A second example of a putative
mammalian scaffold protein was identified by studies of the
JNK signal transduction pathway. The putative scaffold protein
JIP1 (10) binds the MAPK JNK, the MAPKK MKK7, mem-
bers of the MLK group of MAPKKK, and the Ste20-related
protein kinase HPK1 (60). The JIP1 scaffold potentiates the
activation of JNK caused by members of the MLK group of
MAPKKK but does not participate in signaling by the MEKK
group of MAPKKK (60). The JIP group of putative scaffold
proteins includes the structurally related proteins JIP1 and
JIP2 (70).
The JIP3 group of mammalian scaffold proteins. We have
identified a new class of scaffold proteins that may function to
regulate MAPK signaling in mammals. The founding members
of this group include the JIP3a and JIP3b proteins, which
appear to represent the protein products of alternatively
FIG. 9. NGF regulates the expression of JIP3. (A) JIP3 expression was in-
duced by treatment of PC12 cells with NGF. PC12 cells were differentiated to a
neuron-like phenotype by culture in the presence of NGF for 12 days. The
expression of JIP3 was examined by immunoblot analysis using preimmune and
immune sera prepared from a rabbit immunized with recombinant JIP3. Control
experiments were performed with COS7 cells transfected with an empty expres-
sion vector or with a JIP3 expression vector. (B) Expression of JIP3 by PC12 cells
treated with NGF for various times was examined by immunoblot analysis.
Extracts prepared from COS cells transfected with a JIP3b expression vector
were examined in control experiments (JIP3). (C) Differentiated PC12 cells (1
NGF) were deprived of NGF (2 NGF) for 24 h in the presence and absence of
the caspase inhibitor zVAD (0.05 mM). Both the adherent (Adher.) and non-
adherent (Non-Adher.) populations of cells were collected. The expression of
JIP3 was examined by immunoblot analysis. (D) JIP3b (residues 1 to 781) was
prepared by in vitro translation in the presence of [35S]methionine and incubated
in the absence (2) or presence (1) of recombinant active caspase 1 (Casp-1) and
caspase 3 (Casp-3). The effect of caspase digestion was examined following
SDS-PAGE by autoradiography. Control experiments were performed with in
vitro-translated PARP, which is a substrate of caspase 3. (E) In vitro-translated
JIP3b (residues 1 to 781) was incubated without (2) and with (1) caspase 3 in
the presence of the caspase inhibitors zVAD and DEVD (0.1 and 0.01 mM). The
effect of caspase digestion was examined following SDS-PAGE by autoradiog-
raphy. (F) Mutational analysis of the caspase 3 consensus site in JIP3. In vitro-
translated JIP3b (residues 1 to 781) was incubated without (2) and with (1)
caspase 1 and caspase 3. The effect of the replacement of Asp-344 with Glu in the
predicted caspase 3 cleavage site of JIP3 was investigated. The products of
caspase digestion were examined following SDS-PAGE by autoradiography.
Sizes in panels C to F are indicated in kilodaltons.
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spliced transcripts derived from the JIP3 gene. The JIP3 group
of proteins includes JIP3b (accession no. AB11088) and JIP3g
(accession no. X91879), which are structurally related to JIP3
(50, 55). Both JIP3 (Fig. 1) and JIP3b (55) are expressed in the
brain, while JIP3g appears to be most highly expressed in testis
(50).
The JIP3 proteins interact with the MAPK JNK (Fig. 2), the
MAPKK MKK7 (Fig. 4), and the MAPKKK MLK3 (Fig. 5).
These binding interactions are similar to those of JIP1 and
JIP2, which also bind JNK, MKK7, and MLK3. However, un-
like JIP1 and JIP2, which bind several members of the mixed-
lineage protein kinase group of MAPKKKs (including DLK,
MLK2, and MLK3), the JIP3 proteins appear to selectively
interact with MLK3. Transfection studies demonstrate that
JIP3 potentiates the activation of JNK caused by MLK3 (Fig.
7). Thus, the JIP3 proteins may function as molecular scaffolds
for the JNK signaling pathway.
JIP3 scaffold proteins may function as oligomers. Copre-
cipitation assays demonstrated that JIP3 proteins can form
oligomeric complexes, which may be dimers or higher-order
aggregates (Fig. 8). Deletion analysis indicated that the NH2-
terminal region of JIP3, which includes an extended coiled coil
domain, was sufficient for the interaction of JIP3 molecules.
This oligomeric structure of JIP3 is interesting because similar
FIG. 10. Subcellular localization of JIP3. PC12 cells differentiated in the presence of NGF for 12 days were fixed and processed for dual-label indirect
immunofluorescence microscopy. The cells were stained with an antibody to JIP3 (red), neuron-specific enolase (red), and tubulin (green). Competition experiments
were performed by including recombinant JIP3 (10 mg/ml) in the incubation with the primary antibody.
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oligomeric complexes have been detected for other scaffold
proteins, including the JIP1 and JIP2 proteins (70) and Ste5p
(13, 23, 66). Studies of yeast demonstrate that the interaction
between Ste5p molecules facilitates MAPK activation. Fur-
thermore, interallelic complementation assays indicate that
signal transmission through the MAPK module may occur in
trans between protein kinases tethered to different Ste5p mol-
ecules (22). Thus, the function of scaffold proteins may be to
aggregate components of the MAPK module to facilitate ac-
tivation. Whether the oligomeric structure of the mammalian
JIP scaffold proteins is essential for their function to potentiate
JNK activation is not known. Testing this hypothesis will re-
quire the construction of mutated JIP proteins that are unable
to oligomerize but retain the ability to bind MLK3, MKK7, and
JNK.
The JIP1 and JIP2 proteins are known to form both homo-
oligomeric and hetero-oligomeric complexes (70). This obser-
vation suggested that JIP3 proteins might interact with JIP1
and JIP2. Coprecipitation assays provided no evidence for the
interaction of JIP1 with JIP3. However, JIP2 was found to
interact with JIP3 (Fig. 8). Interestingly both JIP3 (Fig. 1) and
JIP2 (70) are selectively expressed in the brain. Further studies
are required to test the hypothesis that the interaction of the
JIP3 and JIP2 scaffolds is relevant to the physiological function
of these proteins. Expression of JIP proteins in COS cells
(which do not express endogenous JIP1, JIP2, or JIP3) dem-
onstrates that each of these proteins can potentiate JNK acti-
vation (Fig. 7). Thus, hetero-oligomeric complex formation by
these putative scaffolds is not required for JNK activation.
However, the observation of hetero-oligomeric complexes of
JIP2 and JIP3 scaffold proteins suggests a mechanism by which
combinatorial specificity of regulation may be conferred by the
formation of specific scaffold assemblies in vivo. This specula-
tive hypothesis warrants further study.
Subcellular location of MAPK scaffold proteins. Studies of
PC12 cells demonstrated that JIP3 expression was induced
during neuron-like differentiation caused by NGF (Fig. 9).
Withdrawal of NGF from differentiated PC12 cells caused a
marked reduction of JIP3 expression which was mediated, in
part, by caspase activation during apoptosis and the proteolysis
of JIP3 (Fig. 9). Immunofluorescence analysis demonstrated
that JIP3 was located in the cytoplasm and was accumulated in
the growth cones of the developing neurites (Fig. 10). This
distribution of JIP3 is similar to that detected for the JIP1 and
JIP2 scaffold proteins, which also accumulate in growth cones
(70). It is tempting to speculate that the growth cone location
of the JIP proteins may indicate that these putative scaffolds
contribute to JNK activation in these subcellular structures.
However, it is also possible that the immunofluorescence im-
ages of fixed cells are a misleading representation of a more
dynamic localization in vivo. Indeed, recent studies of Ste5p
indicate that this yeast scaffold protein is recruited to phero-
mone-induced cell projections, where it activates the mating
MAPK module (40) by a mechanism that requires the traffick-
ing of Ste5p through the nucleus (33). Similar studies of the
dynamics of scaffold protein localization in mammalian cells is
required.
Conclusions. The JIP3, JIP3b, and JIP3g proteins represent
a group of potential scaffold proteins that may function to
regulate the activation of the JNK MAPK module. We present
evidence that JIP3 binds components of a JNK signaling mod-
ule (MLK3, MKK7, and JNK) and functions to potentiate JNK
activation. Biochemical analysis of JIP3b and JIP3g proteins
will be required to establish whether these proteins have sim-
ilar properties. These putative JIP3 scaffold complexes may
aggregate components of a signaling module that activates
JNK in a discrete cellular compartment. These JIP3 signaling
complexes may function in a manner that is physiologically
nonredundant with other mechanisms of JNK activation, in-
cluding complexes with JIP1 and JIP2 proteins (60, 70) or
MEKK proteins (54, 63, 65) and non-scaffold-mediated JNK
activation (61). Genetic dissection of these alternative mecha-
nisms of JNK activation will be required to identify the phys-
iological role of each pathway.
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